Skip to main content

Research Repository

Advanced Search

Pathogenic LRRK2 variants are gain-of-function mutations that enhance LRRK2-mediated repression of beta-catenin signaling

Berwick, D C; Javaheri, B; Wetzel, A; Hopkinson, M; Nixon-Abell, J; Granno, S; Pitsillides, A A; Harvey, K

Authors

D C Berwick

B Javaheri

A Wetzel

M Hopkinson

J Nixon-Abell

S Granno

A A Pitsillides

K Harvey



Citation

Berwick, D. C., Javaheri, B., Wetzel, A., Hopkinson, M., Nixon-Abell, J., Granno, S., …Harvey, K. (2017). Pathogenic LRRK2 variants are gain-of-function mutations that enhance LRRK2-mediated repression of beta-catenin signaling. Molecular Neurodegeneration, 12(9), https://doi.org/10.1186/s13024-017-0153-4

Journal Article Type Article
Acceptance Date Jan 6, 2017
Publication Date Jan 19, 2017
Deposit Date Apr 8, 2017
Publicly Available Date Mar 29, 2024
Journal Molecular Neurodegeneration
Publisher BioMed Central
Peer Reviewed Peer Reviewed
Volume 12
Issue 9
DOI https://doi.org/10.1186/s13024-017-0153-4
Public URL https://rvc-repository.worktribe.com/output/1393772

Files





You might also like



Downloadable Citations